This volume summarizes the current state of knowledge in the economic literature of management of agricultural biotechnology and biodiversity in agricultural and economic development. It identifies key issues confronting policy makers in managing biodiversity and biotechnology and provides a broad, multi-disciplinary analysis of the linkage between the two. It is especially innovative in its use of plant genetic resource management as the basis for is analysis.

The book devotes a detailed chapter to each of the four main areas of environmental biotechnology -- wastewater treatment, soil treatment, solid waste treatment, and waste gas treatment -- dealing with both the microbiological and process engineering aspects.

In this timely book, Jan Gregoire Coombs tells why HMOs failed to improve services or control costs. Using Wisconsin's Marshfield Clinic as a case study, Coombs examines the advantages and disadvantages of publicly and privately financed medical care, and of nonprofit and for-profit systems; the implications of benefits coverage and pharmaceutical costs on employers, employees and patients; and issues involving medical ethics and autonomy, clinical practice guidelines, managed care strategies, rationing, and patients' rights.

Drawing upon a wealth of research, Coombs compares HMOs throughout the nation with the one in Marshfield, which came as close as any HMO to realizing the ideal of early advocates. This book is a vital resource for specialists in the fields of health policy research and analysis, health care management, health law and politics, public health, and social and organizational history of medicine. It will also appeal to many readers who are disturbed by the current state of America's health care system and are curious about its future.

Volume 1: Nanostructured Biomaterials
Volume 2: Applications in Nanobiotechnology

In Africa, the continent where Dr. Wambugu was born, more than 5,000 people die each day from lack of food. Over 30 million children do not have the required nutrition to live a normal healthy life.

Faced with this grim situation, it is refreshing to see how a simple technology can transform the lives of thousands of poor farmers, who then in turn transform their communities. In this book, she writes about real life stories of people who have benefited from planting tissue culture, or clean planting banana seedlings from the lab. If this simple form of technology can change the lives of people, imagine how other sophisticated technologies, such as agribiotech, could possibly transform whole countries? The possibilities are endless.

This book is about the nuts and bolts of technology transfer to communities far removed from science and technology. It takes you through a journey that will leave you convinced that through technology, poverty and hunger can be defeated once and for all.

Over the last three decades, knowledge on the molecular biology of human cancers has vastly expanded. A host of genes and proteins involved in cancer development and progression have been defined and many mechanisms at the molecular, cellular and even tissue level have been, at least partly, elucidated. Insights have also been gained into the molecular mechanisms underlying carcinogenesis by chemical, physical, and biological agents and into inherited susceptibility to cancer.

Accordingly, Part I of the book presents many of the molecules and mechanisms generally important in human cancers. Following an overview on the cancer problem, individual chapters deal with cancer genetics and epigenetics, DNA damage and repair, oncogenes, tumor suppressors, regulatory pathways in cancer, apoptosis, cellular senescence, tumor invasion, and metastasis.

A consensus is emerging that while these common mechanisms and molecules are all relevant to human cancers, in each cancer type (or even subtype) a selection of them are extremely important. For selected cancers, the route from genetic and epigenetic changes to their biological and clinical behavior can already be traced. Part II of the book presents a broad, but exemplary selection of cancers that serve as paradigms to illustrate this point.

In fact, cancer research has now reached a critical stage, in which the accumulated knowledge on molecular mechanisms is gradually translated into improved prevention, diagnosis, and treatment. The state, pitfalls, and potential of these efforts are summarized in Part III.

More than ever, cancer research is now an interdisciplinary effort which requires a basic knowledge of commonly used terms, facts, issues, and concepts. The aim of this book is to provide advanced students and practitioners of different disciplines with this basis, bridging the gap between standard textbooks of molecular biology, pathology, and oncology on the one hand and the specialized cancer literature on the other.

Written by an author with nearly four decades of experience in R&D, technology development, and education and training, this heavily illustrated resource details the fundamental principles of operation and the performance parameters of a wide variety of instruments, including: recording and monitoring instruments, measurement and analysis techniques, therapeutic equipment, digital radiographic equipment, nuclear medical imaging, lithotriptors, anesthesia machines, ventilators, radiotherapy equipment, and automated drug delivery systems.

This book offers new empirical evidence to address such questions by studying the diversity of biotechnology in Europe. By analyzing the way in which the development of new knowledge and information is linked with economic transformation, the authors are able to provide a rich theoretical understanding of the economic dynamics of knowledge within the biotechnology sector. They clearly show how innovation opportunities are affected not just by the market, but by scientific developments, networks, institutions and government policy. They also raise important theoretical questions about how and why new industries, networks and organizations are shaped, and highlight the development and impacts of biotechnology on many existing sectors, including pharmaceuticals, agriculture and insurance. The final chapter summarizes the theoretical challenges which have been overcome and identifies future areas for research.

Agricultural biotechnology has become a national and necessary mainstay of farming and food production, and this book is an important scientific tool to keep you informed of the latest protocols of genetic transformation. This book also outlines the goals that scientists are striving to reach, such as targeted gene expression where the gene only expresses itself at a certain time in the plant’s life cycle, but disappear before human consumption. One of the greatest concerns is maintaining the welfare of the consumer, and in this volume the authors repeatedly discuss their findings in terms of safety for human consumption.

Focusing on the assessment of risks and relative risks on the basis of clinical investigations, this book is supplemented with helpful graphs, charts, and tables as well as references to its web site for larger data sets and exercises.  Comprehensive coverage of classical and modern methods of biostatistics is provided as the book develops basic concepts and derives biostatistical methods through both the application of classical mathematical statistical tools and more modern likelihood-based theories.

The first half of the book presents methods for the analysis of single and multiple 2x2 tables for cross-sectional, prospective, and retrospective (case-control) sampling, with and without matching using fixed and two-stage random effects models. The text then moves on to present a more modern model-based approach, which includes unconditional and conditional logistic regression; the analysis of count data and the Poisson regression model; and the analysis of event time data, including the proportional hazards and multiplicative intensity models. The book contains a technical appendix that presents the core mathematical statistical theory used for the development of classical and modern statistical methods.

Written by John M. Lachin (professor of statistics and biostatistics at the George Washington University in Washington, D.C., and director of the Biostatistics Center in Rockville, Maryland), the book is considered to be an excellent guide for graduate-level students in biostatistics and an invaluable reference for biostatisticians, applied statisticians, and epidemiologists.